| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 21.089 | 58.989 | 820.631 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 21.089 | 58.989 | 821.481 |
| Total Expenses - EUR | - | - | - | - | - | - | 17.394 | 29.888 | 41.228 | 939.172 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -17.394 | -8.799 | 17.762 | -117.691 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -17.394 | -9.010 | 17.172 | -117.691 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Session Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 407.124 | 642.920 | 612.018 | 480.540 |
| Current Assets | - | - | - | - | - | - | 729.757 | 729.963 | 746.562 | 19.597 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 16.882 | 0 |
| Receivables | - | - | - | - | - | - | 726.680 | 728.935 | 726.868 | 18.250 |
| Cash | - | - | - | - | - | - | 3.077 | 1.029 | 2.813 | 1.347 |
| Shareholders Funds | - | - | - | - | - | - | -17.394 | -26.418 | -9.166 | -126.806 |
| Social Capital | - | - | - | - | - | - | 0 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.154.275 | 1.399.301 | 1.367.746 | 626.943 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6811 - 6811" | |||||||||
| CAEN Financial Year |
6810
|
|||||||||
Comments - Session Med S.r.l.